# Intensive Therapy Combined With Venetoclax for Adult Acute Myeloid Leukemia

> **NCT05356169** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Institute of Hematology & Blood Diseases Hospital, China** · enrollment: 312 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** with or without venetoclax

## Key facts

- **NCT ID:** NCT05356169
- **Lead sponsor:** Institute of Hematology & Blood Diseases Hospital, China
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-05-19
- **Primary completion:** 2026-05-15
- **Final completion:** 2027-10-15
- **Target enrollment:** 312 (ACTUAL)
- **Last updated:** 2025-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05356169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05356169, "Intensive Therapy Combined With Venetoclax for Adult Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05356169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*